{"data":{"id":5009,"citation":"Jarc T, Novak M, Hevir N, Ri\u017ener TL, Kreft ME, Kristan K.: Demonstrating suitability of the Caco-2 cell model for BCS-based biowaiver according to the recent FDA and ICH harmonised guidelines.. The Journal of pharmacy and pharmacology, Volume 71 (8), 1231-1242, 2019","title":"Demonstrating suitability of the Caco-2 cell model for BCS-based biowaiver according to the recent FDA and ICH harmonised guidelines.","doi":"10.1111\/jphp.13111","doi_url":"https:\/\/doi.org\/10.1111\/jphp.13111","pmid":"31155721","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/31155721\/","year":2019,"journal":"The Journal of pharmacy and pharmacology","volume":"71","issue":"8","page":"1231-1242","authors":[{"first_name":"Tina","last_name":"Jarc","full_name":"Jarc T"},{"first_name":"Ma\u0161a","last_name":"Novak","full_name":"Novak M"},{"first_name":"Neli","last_name":"Hevir","full_name":"Hevir N"},{"first_name":"Tea Lani\u0161nik","last_name":"Ri\u017ener","full_name":"Ri\u017ener TL"},{"first_name":"Mateja Erdani","last_name":"Kreft","full_name":"Kreft ME"},{"first_name":"Katja","last_name":"Kristan","full_name":"Kristan K"}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/5009","landing_page":"https:\/\/molmedb.upol.cz\/publication\/5009","created_at":"2026-07-13T07:37:51.000000Z","updated_at":"2026-07-13T07:37:51.000000Z"}}